PriceSensitive

Advanced Human Imaging (ASX:AHI) signs marketing agreement with Tinjoy

Health Care
ASX:AHI      MCAP $22.60M
26 April 2021 11:30 (AEST)
Advanced Human Imaging (ASX:AHI) - Chairman & CEO Vlado Bosanac

Source: AHI

Advanced Human Imaging (AHI) has signed a marketing agreement with Tinjoy Biotech ahead of the launch of the companies’ combined product.

The two businesses signed an agreement in February this year to integrate AHI’s BodyScan and FaceScan technology into Tinjoy’s WinScan offering.

At this stage, AHI and Tinjoy’s integrated product is on track to launch in July, while the ASX-lister’s CompleteScan technology will eventually be integrated into WinScan as well.

Ahead of that final integration, a marketing strategy has been implemented with 500 call centre team members being trained in demonstrating the functionality of the integrated WinScan offering.

Meanwhile, Advanced Human Imaging has announced today it’ll hand over US$200,000 (around A$258,000) in three tranches to Tinjoy to help this planned promotion of the integrated product.

This specific promotion is also designed to help Tinjoy work towards hitting the agreed target of an initial one million monthly active users as part of its overall agreement with AHI.

Tinjoy currently services around 28 million monthly consumers both digitally and in person in China with its various health offerings.

“We will be offering the CompleteScan experience to all of our customers as a
way to have them monitor their personal health and then communicate this back to our teams to deliver better more understandable care,” Tinjoy Executive Director Russell Bateman said.

“We are excited to work with Advanced Human Imaging and to bring this comprehensive and innovative digital health evaluation platform to WinScan and the enormity of the China market,” he added.

Advanced Human Imaging Chairman and CEO Vlado Bosanac said the integration with WinScan was progressing well.

“Our teams have been in constant communications over the last 8 weeks progressing the application integration points,” the AHI CEO said.

“The production is moving well, and Russell has been a major driver on the Tinjoy side, making sure communication flows and we meet our target release date,” he added.

Shares in Advanced Human Imaging have opened this week’s trading session down a slight 2.51 per cent at $1.75 per share.

Related News